ロード中...
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases
BACKGROUND: FOXA1 expression is a good prognostic marker for endocrine therapy in hormone-positive breast cancer. We retrospectively examined breast cancer patients with luminal human epidermal growth factor receptor 2 (HER2)-negative tumours, as defined by immunohistochemistry, who received neo-adj...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4453454/ https://ncbi.nlm.nih.gov/pubmed/25422910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.595 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|